Jun 30, 2019

United Therapeutics Q2 2019 Earnings Report

Total Revenue
$374M
Previous year: $445M
-16.0%
EPS
$3.63
Previous year: $4.36
-16.7%
Gross Profit
$347M
Previous year: $383M
-9.4%
Cash and Equivalents
$881M
Previous year: $746M
+18.2%
Free Cash Flow
$113M
Previous year: $126M
-10.8%
Total Assets
$3.9B
Previous year: $3.24B
+20.2%

United Therapeutics

United Therapeutics

United Therapeutics Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income